Craig Muir - Global Blood Insider

Global Blood Therapeutics Inc -- USA Stock  

USD 32.55  0.55  1.72%

Founder and Advisor

We currently do not have informatin regarding Craig Muir. This executive tanure with Global Blood Therapeutics Inc is not currenlty determined.
        
650-741-7700  http://www.globalbloodtx.com

Management Efficiency

The company has Return on Asset of (22.45) % which means that on every $100 spent on asset it lost $22.45. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (37.85) % meaning that it generated no profit with money invested by stockholders.

Entity Summary

Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous bloodbased disorders. Global Blood Therapeutics Inc (GBT) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 55 people. Global Blood is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Global Blood Therapeutics Inc to your portfolio

Top Management

Global Blood Therape Leadership Team
Michael Bonney, Director
Jeffrey Farrow, CFO
Philip Pizzo, Director, Ph.D
Hing Sham, President, Ph.D
Scott Morrison, Director
Deval Patrick, Director
Charles Homcy, Director
Craig Muir, Founder
Ted Love, CEO
Jung Choi, Executive, MBA
Lesley Calhoun, President
Mark Perry, Director
Myesha Edwards, Executive
Eleanor MD, Executive
Matthew Jacobson, Founder
Glenn Pierce, Director
Willie Brown, Director
Ted MD, CEO
Kevin Starr, Director
David Phillips, Founder
Tricia Suvari, Executive
Peter Radovich, President, MBA
Eleanor Ramos, Executive
John Schembri, President
Charles MD, Director

Stock Performance

Global Blood Performance Indicators